Phase IV Multicentric Study, 140 Patients Suffering of Meibomian Glands Dysfunction.

Status: Completed
Location: See all (29) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Multicentric study, open label, uncontrolled phase IV in 140 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized. This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21. Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Healthy Volunteers: No
View:

• Best corrected far visual acuity (VA) > 1/10

Locations
Other Locations
France
CHU d'Amiens
Amiens
Hopital Pellegrin
Bordeaux
CHU de Dijon
Dijon
76 Allée des Pins Tranquilles
Hossegord
CHU de Bicêtre
Le Kremlin Bicãªtre
Hopital Claude Huriez
Lille
Hopital Dupuytren
Limoges
Hopital Edouard Heriot
Lyon
433 bis rue Paradis
Marseille
Hopital d'instruction des armées LAVERAN
Marseille
67 chemin du Fescau
Montferrier Sur Lez
60 place Jacques Mirouze
Montpellier
3 cours Leopold
Nancy
Hopital Max Fourestier
Nanterre
4 avenue Baquis
Nice
Centre Hospitalier de Nimes
Nimes
142 Boulevard de Montparnasse
Paris
22 rue Beaujon
Paris
C.H.N.O des XV-XX
Paris
Fondation Rothschild
Paris
Hotel Dieu
Paris
26 rue du Moulin des justices
Puilboreau
Polyclinique Saint Laurent
Rennes
CHU de Saint Etienne
Saint Etienne
CHU Hospices Civils
Strasbourg
Hôpital de Tarbes
Tarbes
Clinique du Cours Dillion
Toulouse
CHU Bretonneau
Tours
Hopital Brabois Adulte
Vandoeuvre Les Nancy
Time Frame
Start Date: June 2010
Completion Date: December 2011
Participants
Target number of participants: 104
Authors
Philippe GAIN, Tristan BOURCIER, Pierre LABALETTE, Karim LAOUAR, Damien GATINEL, Bruno MORTEMOUSQUE, Marc LABETOULLE, Stephane RONCIN, Jean Louis BOURGES, Philippe IMBERT, Yves UTEZA, Pierre Jean PISELLA, Michel TAZARTES, Hervé CHENAL, Sylvie MAINGUY, Pierre Yves ROBERT, Solange MILAZZO, Jean Paul ADENIS, Stephan FAUQUIER, Carole BURILLON, Vincent BORDERIE, Olivier Galatoire, Benoit BRIAT, Sylvie MAES CASTELLARIN, Claude SPEEG, Claire MEURIOT TUIL, Jean Luc GEORGES, Frank ROUX, Philippe CAZEMIND, Thanh HOANG XUAN, Isabelle BADELLON, Denis FLORES, Catherine CREUZOT GARCHER, Jean François ROULAND, Dominique BREMOND GIGNAC, Joseph COLIN
Sponsors
Leads: Laboratoires Thea

This content was sourced from clinicaltrials.gov